Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Common Stock | Options Exercise | $452K | +2.19K | +73.34% | $206.62 | 5.17K | Feb 16, 2023 | Direct | |
transaction | IDXX | Common Stock | Sale | -$1.12M | -2.19K | -42.31% | $511.68 | 2.98K | Feb 16, 2023 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IDXX | Non-Qualified Stock Option (right-to-buy) | Options Exercise | -2.19K | -100% | 0 | Feb 16, 2023 | Common Stock | 2.19K | $206.62 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | Represents the weighted average price of the shares sold ranging from a low of $511.65 to a high of $512.29 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. |
F2 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment on May 8, 2019, the date of the 2019 annual meeting of shareholders. |
F3 | Not applicable. |